MicrobeWorld App

appsquarebannerad200x200

Join MicrobeWorld

Subscribe via Email

subscribe

Microbes After Hours

MW-Site-Banner-200x200

Click for more "Microbes After Hours" videos

Featured Image

Featured Video

Crowdsourced Microbes Heading to Station

Supporters

ASM House 200X200

First Clinical Trial Results for Yellow Fever Vaccine

Xcellerex, Inc., a leader in rapid deployment, single-use biomanufacturing solutions, today announced positive results of a Phase I clinical trial of its investigational vaccine against yellow fever virus, XRX-001. In the study, the vaccine was well tolerated and induced neutralizing antibodies in 100 percent of subjects receiving a high dose and 88 percent receiving a low dose. The results are published in the April 7, 2011 edition of the New England Journal of Medicine.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use